Resistant cancer cell-derived EVs can carry drug transporters, such as P-glycoprotein, to promote drug efflux in nearby sensitive cells or even carry miRNAs to induce the expression of genes related to membrane transporters (12). The gene discussed is ABCB1; the disease is cancer.